Stay updated on OV101 in Fragile X Syndrome: Clinical Trial
Sign up to get notified when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.

Latest updates to the OV101 in Fragile X Syndrome: Clinical Trial page
- Check2 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 error page.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study record page now shows a 403 Forbidden message replacing the content and provides a Home link, indicating restricted access to the study details.SummaryDifference17%

- Check30 days agoChange DetectedRevision updated in the Study Documents section from v3.6.6 to v3.7.0. This appears to be a metadata/version control update and does not modify the study data, eligibility criteria, outcomes, or other substantive content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe study record now lists Ovid Therapeutics Inc. as sponsor and attaches Healx AI to Ovid Therapeutics Inc. as a collaborator (replacing a standalone Healx AI entry). This reflects a reorganization of the study's organizational affiliations.SummaryDifference0.3%

- Check44 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6. This reflects a small on-page update to versioning information.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, reflecting a new page build. This indicates an internal update to the page template or content management system rather than a modification to study details or user-facing information.SummaryDifference0.1%

Stay in the know with updates to OV101 in Fragile X Syndrome: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OV101 in Fragile X Syndrome: Clinical Trial page.